tetrabenazine has been researched along with Adverse Drug Event in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Jankovic, J; Makhoul, K | 1 |
| Arya, D; Fernandez, HH; Khan, T; Margolius, AJ | 1 |
| Akbostanci, MC; Sahin, T; Yilmaz, R | 1 |
| Bozigian, H; Jimenez, R; Loewen, G; Luo, R; O'Brien, CF | 1 |
| Burke, J; Jimenez, R; Liang, GS; O'Brien, CF; Thai-Cuarto, D | 1 |
| Limandri, BJ | 1 |
| Hussar, DA | 1 |
| Chang, HP; Hsiao, IT; Kung, MP; Lin, KJ; Lu, CS; Skovronsky, D; Weng, YH; Wey, SP; Yen, TC | 1 |
| Chase, TN | 1 |
2 review(s) available for tetrabenazine and Adverse Drug Event
| Article | Year |
|---|---|
Tardive Dyskinesia: Treatment Update.
Topics: Antipsychotic Agents; Dopamine Antagonists; Drug-Related Side Effects and Adverse Reactions; Humans; Quality of Life; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2019 |
Drug-induced extrapyramidal disorders.
Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopamine; Drug-Related Side Effects and Adverse Reactions; Extrapyramidal Tracts; Haloperidol; Humans; Methyltyrosines; Movement Disorders; Phenothiazines; Phenylacetates; Probenecid; Reserpine; Synaptic Transmission; Tetrabenazine; Tranquilizing Agents; Trihexyphenidyl | 1972 |
2 trial(s) available for tetrabenazine and Adverse Drug Event
| Article | Year |
|---|---|
Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects.
Topics: Adrenergic Uptake Inhibitors; Adult; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Male; Tardive Dyskinesia; Tetrabenazine; Valine; Vesicular Monoamine Transport Proteins | 2017 |
Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent.
Topics: Drug-Related Side Effects and Adverse Reactions; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Molecular Imaging; Parkinson Disease; Positron-Emission Tomography; Radiometry; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2010 |
5 other study(ies) available for tetrabenazine and Adverse Drug Event
| Article | Year |
|---|---|
Real-world experience with VMAT2 inhibitors in Tourette syndrome.
Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Retrospective Studies; Tardive Dyskinesia; Tetrabenazine; Tics; Tourette Syndrome; United States; Vesicular Monoamine Transport Proteins | 2023 |
Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Chorea; Drug-Related Side Effects and Adverse Reactions; Dystonic Disorders; Female; Humans; Hyperkinesis; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary; Tardive Dyskinesia; Tetrabenazine; Tic Disorders; Turkey; Young Adult | 2020 |
Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials.
Topics: Aged; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Heart Rate; Humans; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Tardive Dyskinesia; Tetrabenazine; Valine | 2018 |
Tardive Dyskinesia: New Treatments Available.
Topics: Antipsychotic Agents; Chlorpromazine; Drug-Related Side Effects and Adverse Reactions; Humans; Psychiatric Nursing; Tardive Dyskinesia; Tetrabenazine; Valine | 2019 |
New drugs 09, part 2.
Topics: Adrenergic Uptake Inhibitors; Angioedemas, Hereditary; Benzoates; Carrier Proteins; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Fluprednisolone; Humans; Huntington Disease; Hydrazines; Keratitis; Nurse's Role; Ophthalmologic Surgical Procedures; Pain, Postoperative; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Pyridines; Receptors, Fc; Recombinant Fusion Proteins; Tetrabenazine; Thrombopoietin; Uveitis | 2009 |